Skip to main content
NewslettersWatchlist

Can B Corp(CANB)
OTC US

Today's Change
Delayed Last Update
Day Low0.0260
Day High0.0300
Open:0.0265
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
TheNewswire.com
Can B Corp. Secures Ownership and Control of Two Cannabis Patents Valued at $122 Million and Potentially in Excess of $750 Million
Globe Newswire
Can B Corp. Inks Manufacturing & Distribution Agreement for Superfood Products with Forever Brands and Brooke Burke via BB Body, Inc.
Globe Newswire
Can B Corp. Reports First Quarter Revenue Growth of 606% to $1.9 Million, the Highest Quarterly Revenue in Company History
Globe Newswire
Can B Corp. to Present at the Emerging Growth Conference on Wednesday, April 27, 2022
Globe Newswire
Can B Corp. and American Development Partners Agree to Finance and Develop CBD Lounges
Globe Newswire
Can B Corp. Executes Joint Venture with PrimeX Making its CBD Products Available in Brazil
AccessWire
Can B Corp.’s Pure Health Products Awarded NSF’s GMP Certification
AccessWire
Can B Corp. Reports 316% Revenue Growth to a Quarterly Revenue Record of $1.9 Million for its Third Quarter 2021
Globe NewsWire
CEO Presenting on the Emerging Growth Conference on September 29 Register Now
AccessWire
Can B Corp. to Produce 13,000 Liters of Delta-8 and Other Isomers with Potential $10 Million Revenue
AccessWire
Can B Corp. Secures Lease for 300,000 Square Foot Facility in McMinnville, Tennessee
Globe NewsWire
Can B Corp. Strengthens Its Vertical Processing Capabilities With Acquisition of Assets From Music City Botanicals
AccessWire
Can B Corp. Closes Acquisition of Assets from Music City Botanicals to Strengthen its Vertical Processing Capabilities
AccessWire
Can B Corp. Reports 96% Revenue Growth for Its Second Quarter 2021
Globe NewsWire
Four Cannabis Companies Capitalizing On Increased CBD Demand
AccessWire
Can B Corp. Closes Acquisition of Assets from TWS Pharma in CO to Significantly Expand Capabilities in Converting Hemp Biomass to Isolate Used in our CBD and Isomer Product Lines
AccessWire
Can B Corp. Partners with Group of Professional Hollywood Stuntmen and World Champion Action Sports Athletes for CBD Products, Expects to Launch New CBD Brand by End of Summer
AccessWire
Can B Corp Announces First Quarter 2021 Results
AccessWire
Can B Corp. Enters the Industrial Hemp Business
AccessWire
Can B Corp. Announces Full Year 2020 Results
AccessWire
Can B Corp. to Present at Virtual Investor Summit on March 23, 2021 at 3:00 PM ET
AccessWire
Can B Corp. Acquires Assets from Leading-Edge Hemp Technology Group
AccessWire
Can B Corp. Executes Definitive Agreement to Acquire the Assets of Imbibe Health Solutions
Globe NewsWire
Can B Corp Partners with Signature PR to Launch a New Premier Line
Globe NewsWire
Can B Corp. Accelerates its Innovations and Advancements at Pure Health Products
Globe NewsWire
Can B Corp and Dr. Karl Zarse Launch ImmuneX2
Globe NewsWire
Can B Corp. Provides Highlights for 2020 and Preview of 2021
Globe NewsWire
Can B Corp Closes $2.8 Million New Financing
Globe NewsWire
Can B Corp to Present at The 13th Annual LD Micro Main Event Conference
Globe NewsWire
Can B Corp Announces Third Quarter 2020 Results
Globe NewsWire
Can B Corp Triples Production at its Facility in Lacey, Washington
Globe NewsWire
Can B Corp Products, FDA Approved Medical Devices, Subsidiaries and Medical Team Among Topics Discussed by Company Director and CFO Stanley Teeple

Profile

Can B Corp. is a health & wellness company providing hemp-derived cannabinoid products, including under its own brands of Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil and Duramed. It serves consumers, including medical facilities, doctor offices, retailers, online and direct. Can B Corp. is based in HICKSVILLE, NY.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.